STAAR Surgical nimmt an zwei Investorenkonferenzen teil
- STAAR Surgical nimmt am 10. November 2026 an der Stifel 2026 Healthcare Conference in New York teil.
- Am 11. November 2026 folgt dort das Canaccord Genuity MedTech, Diagnostics and Digital Health and Services Forum.
- CEO Warren Foust und Finanzchefin Deborah Andrews vertreten das Unternehmen bei beiden Investorenkonferenzen.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. STAAR Surgical Company published the original content used to generate this news brief via Business Wire (Ref. ID: 20261027858143) on October 27, 2026, and is solely responsible for the information contained therein.